Sarda Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2026 ,inter alia, to consider and approve standalone Audited financial ....
Awaiting price reaction for this filing.
Sarda Proteins Ltd has informed BSE that its Board of Directors meeting is scheduled for April 30, 2026. The meeting will consider and approve standalone Audited financial results for the quarter and financial year ended March 31, 2026. The company has also confirmed that the Trading Window remains closed from April 1, 2026 and will reopen 48 hours after the results are declared. This is a standard procedural intimation filing as required under SEBI (LODR) Regulations, 2015. The actual financial results will be disclosed separately after the board meeting.
This is a routine filing and does not contain any financial data or decisions. The stock is currently in a trading blackout period until results are announced. The actual financial performance and any significant disclosures will be revealed when the audited results are approved and published.